CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss for the period	$ (27,259,804)	$ (7,618,964)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,082,482	621,395
Change in operating lease right-of-use assets	72,322	65,605
Change in fair value of debentures	583,823	0
Loss on extinguishment of debentures	25,000	0
Costs to issue debentures	111,725	0
IPR&D - Teverelix	8,717,475	0
Foreign exchange gain/loss	8,816	0
Non-cash interest expense	89,680	106,253
Loss on SEPA settlements	157,721	0
Issuance cost related to SEPA	300,000	0
Changes in operating assets and liabilities:
Prepaid expenses	317,522	37,358
Deferred issuance costs	0	(684,040)
Accounts payable	(380,033)	235,756
Accrued expenses and other current liabilities	111,167	238,526
Operating lease liability	(106,171)	(35,040)
Related party payable	621	(22,528)
Net cash used in operating activities	(16,167,654)	(7,055,679)
Cash flows from financing activities:
Net proceeds from issuance of common shares and warrants	9,790,015	5,470,000
Proceeds from issuance of shares under SEPA	5,097,005	0
Proceeds from issuance of Debentures	11,866,293	0
Repayment of debentures and other loan	(5,637,709)	0
Proceeds from issuance of convertible notes	0	5,172,500
Proceeds from exercise of warrants	4,729,398	0
Proceeds from exercise of stock options	162,400	0
Costs to issue Debentures	(136,726)	0
Issuance costs for common shares	(584,361)	0
Net cash provided by financing activities	25,286,315	10,642,500
Cash flows from investing activities:
Net cash paid for Antev asset acquisition including transaction costs	(4,619,152)	0
Net cash used in investing activities	(4,619,152)	0
Foreign currency effect on cash and cash equivalents	(1,741)	0
Net increase in cash and cash equivalents during the period	4,497,768	3,586,821
Cash and cash equivalents, beginning of the period	4,164,323	1,719,338
Cash and cash equivalents, end of the period	8,662,091	5,306,159
Supplemental disclosure of non-cash investing and financing activities
Right-of-use assets obtained in exchange for lease liabilities	0	356,805
Deemed dividend on warrant inducement	4,954,518	0
Shares issued for acquisition of Antev	2,129,410	0
Shares to be issued for acquisition of Antev	313,934	0
Issuance costs included in accounts payable	95,360	0
Issuance of shares related to SEPA	$ 300,000	$ 0